Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...

Medtronic (MDT) is a medical device ... monitors inserted into the body that record electrical activity during fainting spells and palpitations and surgical replacements for diseased heart valves.

Dr. Jeffrey Popma, the chief medical officer for the Structural Heart business unit at Medtronic, plans to retire, company ...

The Galien Foundation recently announced the nominees for its "Best Medical Technology" Pix Galien USA awards.

The devices can jump-start a misbehaving heart, resetting its normal rhythm — unless they malfunction first. In 2022, Medtronic recalled more than 85,000 of the devices after dozens of ...

Sept 19 (Reuters) - Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's (MDT.N), opens new tab patent rights in nerve ...

Medtronic's product portfolio is comprised of a variety of life-saving and life-improving medical devices that include implantable defibrillators, heart valves, insulin pumps, glucose monitoring ...

Medtronic beat first-quarter earnings and revenue estimates on strong sales of its medical devices. Sales were higher at the company's cardiovascular, neuroscience, and diabetes divisions.

Tuesday, Medtronic Plc (NYSE ... Structural Heart, and Diabetes. Also Read: Abbott Labs Makes Marketing Push For New Glucose ...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based ... continuous glucose monitoring systems, and insulin pump ...

Our 2024 Women in Medtech edition features insights from Abbott's Lisa Earnhardt, Medtronic's Nina Goodheart, and more.

Medtronic has been consistently growing ... From catheters to neurostimulators to continuous glucose monitoring devices, the company has a broad range of products in its portfolio, and it's ...